ClinicalTrials.Veeva

Menu

Mastocytosis Registry (of Zurich) (MastoR)

University of Zurich (UZH) logo

University of Zurich (UZH)

Status

Enrolling

Conditions

Mastocytosis
Hypertryptasemia

Study type

Observational

Funder types

Other

Identifiers

NCT06466889
BASEC 2020-01568

Details and patient eligibility

About

The study aims to summarize patients with mastocytosis and hypertryptasämia (without underlying mastocytosis or no bone marrow biopsy) in relation to demographic information, clinical progress and treatment courses. Biologic samples are collected from available routine diagnostics (serum, skin tissue, gut mucosa, bone marrow, and others) for further use in experimental research.

Enrollment

400 estimated patients

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Adult patients with mastocytsis/hypertryptasemia which are treated at the university hospital of Zurich
  • available informed consent

Exclusion criteria

  • denied consent

Trial design

400 participants in 2 patient groups

Mastocytosis
Description:
Diagnosed mastocytosis according to WHO criteria
Hypertryptasemia
Description:
Repeated elevated serum tryptase with no underlying mastocytosis or no bone marrow biopsy performed

Trial contacts and locations

1

Loading...

Central trial contact

Claudia Lang, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems